US Demand for Pharmaceuticals to Reach $306 billion in 2021

Biological Products to Drive Sales Gains

News provided by

May 09, 2018, 01:25 ET

CLEVELAND, May 9, 2018 /PRNewswire/ -- Demand for pharmaceuticals in the US is forecast to total $306 billion in 2021, according to Pharmaceuticals: United States, a report recently released by Freedonia Focus Reports. Gains will reflect high-value new product introductions, a steadily aging population, a rising occurrence of diseases and disorders, and trends favoring the use of medication over more costly patient procedures.

More information about the report is available at https://www.freedoniafocusreports.com/Pharmaceuticals-United-States-FF40040/

Demand for biological products is projected to rise at the fastest pace of any segment, due to the launch of several new biologics and broadening market penetration via biosimilar introductions. Meanwhile, demand for anti-infective pharmaceuticals is projected to see the steepest decline of any segment, due to waning revenues from hepatitis C treatments.

These and other key insights are featured in Pharmaceuticals: United States. This report forecasts to 2021 US (including Puerto Rico) demand for pharmaceuticals for human use in nominal US dollars at the manufacturer level. Total demand is segmented by product in terms of:

compounded
biological

Compounded pharmaceutical demand is also segmented by therapeutic class as follows:

hormones and related
central nervous system
anti-infective
cardiovascular
respiratory
nutritional
digestive and genito-urinary
dermatological

To illustrate historical trends, total demand, trade, and the various segments are provided in annual series from 2006 to 2016.

About Freedonia Focus Reports
Each month, The Freedonia Group – a division of MarketResearch.com – publishes over 20 new or updated Freedonia Focus Reports, providing fresh, unbiased analysis on a wide variety of markets and industries. Published in 20-30 pages, Focus Report coverage ranges from raw materials to finished manufactured goods and related services such as freight and construction. Additional Healthcare & Biotechnology reports can be purchased at Freedonia Focus Reports or MarketResearch.com.

Analysis is intended to guide the busy reader through pertinent topics in rapid succession, including: